These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 17588482)

  • 21. Interaction with human stromal cells enhances CXCR4 expression and engraftment of cord blood Lin(-)CD34(-) cells.
    Kobune M; Kawano Y; Takahashi S; Takada K; Murase K; Iyama S; Sato T; Takimoto R; Niitsu Y; Kato J
    Exp Hematol; 2008 Sep; 36(9):1121-31. PubMed ID: 18562079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation.
    Heinzelmann F; Lang PJ; Ottinger H; Faul C; Bethge W; Handgretinger R; Bamberg M; Belka C
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):523-8. PubMed ID: 17869449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Local injection of stem cell factor (SCF) improves myocardial homing of systemically delivered c-kit + bone marrow-derived stem cells.
    Lutz M; Rosenberg M; Kiessling F; Eckstein V; Heger T; Krebs J; Ho AD; Katus HA; Frey N
    Cardiovasc Res; 2008 Jan; 77(1):143-50. PubMed ID: 18006465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of CD34+ cell dose on platelet engraftment in pediatric patients following unmanipulated haploidentical blood and marrow transplantation.
    Chang YJ; Xu LP; Liu DH; Liu KY; Han W; Chen YH; Wang Y; Chen H; Wang JZ; Zhang XH; Zhao XY; Huang XJ
    Pediatr Blood Cancer; 2009 Dec; 53(6):1100-6. PubMed ID: 19743519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective randomized comparative observation of single- versus split-dose lenograstim to enhance engraftment after autologous stem cell transplantation in patients with multiple myeloma or non-Hodgkin's lymphoma.
    Jang G; Ko OB; Kim S; Lee DH; Huh J; Suh C
    Transfusion; 2008 Apr; 48(4):640-6. PubMed ID: 18194384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new red fluorescent protein that allows efficient marking of murine hematopoietic stem cells.
    Sanuki S; Hamanaka S; Kaneko S; Otsu M; Karasawa S; Miyawaki A; Nakauchi H; Nagasawa T; Onodera M
    J Gene Med; 2008 Sep; 10(9):965-71. PubMed ID: 18613301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hematopoietic stem cell engraftment by early-stage in utero transplantation in a mouse model.
    Chen X; Gong XL; Katsumata M; Zeng YT; Huang SZ; Zeng F
    Exp Mol Pathol; 2009 Dec; 87(3):173-7. PubMed ID: 19666020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved granulocyte colony-stimulating factor mobilization of hemopoietic progenitors using cytokine combinations in primates.
    Larsen SR; Chng K; Battah F; Martiniello-Wilks R; Rasko JE
    Stem Cells; 2008 Nov; 26(11):2974-80. PubMed ID: 18719223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stem cell gene transfer: insights into integration and hematopoiesis from primate genetic marking studies.
    Dunbar CE
    Ann N Y Acad Sci; 2005 Jun; 1044():178-82. PubMed ID: 15958711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclosporine inhibits the development of green fluorescent protein (GFP)-specific immune responses after transplantation of GFP-expressing hematopoietic repopulating cells in dogs.
    Beagles KE; Peterson L; Zhang X; Morris J; Kiem HP
    Hum Gene Ther; 2005 Jun; 16(6):725-33. PubMed ID: 15960603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Role of paternal veto cells in preventing graft-versus-host disease after HLA-haploidentical stem cell transplantation in mice].
    Wang SB; Guo KY; Hu DM
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jan; 28(1):79-81. PubMed ID: 18227034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Umbilical cord blood xenografts in immunodeficient mice reveal that T cells enhance hematopoietic engraftment beyond overcoming immune barriers by stimulating stem cell differentiation.
    Hexner EO; Danet-Desnoyers GA; Zhang Y; Frank DM; Riley JL; Levine BL; Porter DL; June CH; Emerson SG
    Biol Blood Marrow Transplant; 2007 Oct; 13(10):1135-44. PubMed ID: 17889349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced survival of bone-marrow-derived pluripotent stem cells in an animal model of auditory neuropathy.
    Matsuoka AJ; Kondo T; Miyamoto RT; Hashino E
    Laryngoscope; 2007 Sep; 117(9):1629-35. PubMed ID: 17632425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retroviral transduction of murine hematopoietic stem cells.
    Haviernik P; Zhang Y; Bunting KD
    Methods Mol Biol; 2008; 430():229-41. PubMed ID: 18370303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preclinical ex vivo expansion of peripheral blood CD34+ selected cells from cancer patients mobilized with combination chemotherapy and granulocyte colony-stimulating factor.
    Lorenzon D; Mazzucato M; Abbruzzese L; Cilli M; De Angeli S; Degan M; Mambrini G; Piccardi F; Rupolo M; Michieli M; De Marco L; Gattei V; Astori G
    Vox Sang; 2008 May; 94(4):342-50. PubMed ID: 18282263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Differential study on the in vivo homing potential of human hematopoietic stem/progenitor cells from different sources in xenotransplanted NOD/SCID mouse model].
    Yang Z; Lu SH; Li YH; Liu B; Wang HJ; Jia HR; Zheng YZ
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jun; 28(6):391-5. PubMed ID: 17939405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytokine-pretreatment of CD34(+) cord blood stem cells in vitro reduces long-term cell engraftment in NOD/SCID mice.
    Wulf-Goldenberg A; Eckert K; Fichtner I
    Eur J Cell Biol; 2008 Feb; 87(2):69-80. PubMed ID: 17931741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-level in vivo gene marking after gene-modified autologous hematopoietic stem cell transplantation without marrow conditioning in nonhuman primates.
    Ueda K; Hanazono Y; Shibata H; Ageyama N; Ueda Y; Ogata S; Tabata T; Nagashima T; Takatoku M; Kume A; Ikehara S; Taniwaki M; Terao K; Hasegawa M; Ozawa K
    Mol Ther; 2004 Sep; 10(3):469-77. PubMed ID: 15336647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Forced myocardin expression enhances the therapeutic effect of human mesenchymal stem cells after transplantation in ischemic mouse hearts.
    Grauss RW; van Tuyn J; Steendijk P; Winter EM; Pijnappels DA; Hogers B; Gittenberger-De Groot AC; van der Geest R; van der Laarse A; de Vries AA; Schalij MJ; Atsma DE
    Stem Cells; 2008 Apr; 26(4):1083-93. PubMed ID: 18203678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S
    Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.